Abstract
The study by Luo et al published in the World Journal of Gastrointestinal Oncology presents a thorough and scientific methodology. Pancreatic cancer is the most challenging malignancy in the digestive system, exhibiting one of the highest mortality rates associated with cancer globally. The delayed onset of symptoms and diagnosis often results in metastasis or local progression of the cancer, thereby constraining treatment options and outcomes. For these patients, prompt tumour identification and treatment strategising are crucial. The present objective of pancreatic cancer research is to examine the correlation between various pathological types and imaging data to facilitate therapeutic decision-making. This study aims to clarify the correlation between diverse pathological markers and imaging in pancreatic cancer patients, with prospective longitudinal studies potentially providing novel insights into the diagnosis and treatment of pancreatic cancer.